Beckermann, Kathryn E.
Rini, Brian I.
Article History
First Online: 23 June 2023
Competing interests
: K.E.B. has received institutional research funding from BMS, Eisai, Exelixis, Pfizer and Merck. K.E.B. has acted as a consultant for BMS and Exelixis. B.I.R. has received institutional research funding and/or has acted as a consultant for BMS, Eisai, Exelixis, Pfizer and Merck.